Data completeness
2/8 — Basic
PROTAMINE SULFATE (protamine sulfate) by Pfizer is clinical pharmacology: when administered alone, protamine has an anticoagulant effect. Approved for the treatment of heparin overdosage.
Drug data last refreshed 9h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Protamine sulfate is an intravenous powder antidote that rapidly neutralizes heparin anticoagulation by forming a stable salt complex. It is indicated for the treatment of heparin overdosage and works within five minutes of IV administration. The drug is essential in acute care settings to reverse unintended heparin toxicity.
Pre-Launch
Pre-launch status suggests early-stage team building for regulatory approval and market entry preparation.
Mechanism of Action
CLINICAL PHARMACOLOGY: When administered alone, protamine has an anticoagulant effect. However, when it is given in the presence of heparin (which is strongly acidic), a stable salt is formed and the anticoagulant activity of both drugs is lost. Protamine sulfate has a rapid onset of action.…
Indications (1)
Career Relevance
Worked on PROTAMINE SULFATE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.